Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)

Clinical trial NCT05013112 · COMPLETED

Trial details

NCT number: NCT05013112
Sponsor: West China Hospital
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Kidney Transplantation Metabolic Disorder Metformin Empagliflozin

Start date: 2023-01-01
Primary completion: 2025-12-31
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.